12/12/2025
Just got this from work!
The problem is that none of those approaches can fully validate a treatment before it reaches human trials. Who among us would take the “cure for cancer” or a new medication that never went through the rigorous preclinical testing that historically kept people safe? There’s a much bigger picture here, and decisions made far above our level ripple out in ways most people don’t see.
My employer has been transparent with us and is doing everything possible to keep the team intact. We’re a company of fewer than 100 employees, second-generation family-owned, and the reason we’ve survived this long is decades of conservative financial planning and owning everything outright. That has allowed us to operate on very slim margins and weather downturns that would have closed many other companies.
Even with all that, we’re now facing reduced hours (see attached notice), and the leadership will reevaluate as conditions change. I suspect the next step—if the market doesn’t turn around—will be headcount reductions.
I’m incredibly grateful to work for owners who are honest with us and trying their hardest to protect everyone’s job. But the situation illustrates how policy shifts at the national level don’t just affect labs—they affect manufacturers, engineers, technicians, suppliers, and ultimately the pace of scientific progress itself.
From what I could find the lower floor is that $15 Billion in funding is no longer going to this entire industry. The company I work for is less than a fraction of 1% of that number, so there are a lot of others.
As I know I will expect to here something about experiments with animals. It is all done very humainely and they are born for the purpose.